We are live on ! Find out more
DGX icon

Quest Diagnostics
DGX

624 hedge funds and large institutions have $9.91B invested in Quest Diagnostics in 2018 Q4 according to their latest regulatory filings, with 70 funds opening new positions, 225 increasing their positions, 217 reducing their positions, and 110 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.31% more ownership

Funds ownership: 86.36% → 88.67% (+2.3%)

4% more repeat investments, than reductions

Existing positions increased: 225 | Existing positions reduced: 217

7% less funds holding

Funds holding: 673 → 624 (-49)

22% less capital invested

Capital invested by funds: $12.7B → $9.91B (-$2.82B)

36% less first-time investments, than exits

New positions opened: 70 | Existing positions closed: 110

47% less call options, than puts

Call options by funds: $21.6M | Put options by funds: $41M

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

Holders
624
Holders Change
-49
Holders Change %
-7.28%
% of All Funds
13.9%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
70
Increased
225
Reduced
217
Closed
110
Calls
$21.6M
Puts
$41M
Net Calls
-$19.3M
Net Calls Change
+$11.5M

Top Buyers

Rank Fund Capital Flow
1
LCS
Levin Capital Strategies
New York
+$135M
2
American Century Companies
American Century Companies
Missouri
+$106M
3
Macquarie Group
Macquarie Group
Australia
+$93.8M
4
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
+$79.1M
5
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$70.7M

Top Sellers

Rank Fund Capital Flow
1
Bessemer Group
Bessemer Group
New Jersey
-$121M
2
Marshall Wace
Marshall Wace
United Kingdom
-$97.7M
3
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB)
Sweden
-$90.9M
4
HM
HealthCor Management
New York
-$79.4M
5
BlackRock
BlackRock
New York
-$72.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Balyasny Asset Management
626
Balyasny Asset Management
Illinois
– -$24.5M -227,374 Closed
Millennium Management
627
Millennium Management
New York
– -$19.6M -181,597 Closed
Verition Fund Management
628
Verition Fund Management
Connecticut
– -$5.34M -49,516 Closed
DHFB
629
Dixon Hubard Feinour & Brown
Virginia
– -$5.14M -47,600 Closed
QT
630
Quantbot Technologies
New York
– -$5.09M -47,192 Closed
SEC
631
Seven Eight Capital
New York
– -$4.9M -45,398 Closed
GCP
632
GSA Capital Partners
United Kingdom
– -$4.48M -41,495 Closed
TI
633
Trexquant Investment
Connecticut
– -$4.43M -41,046 Closed
SGH
634
Sivik Global Healthcare
Connecticut
– -$4.32M -40,000 Closed
VRS
635
Virginia Retirement Systems
Virginia
– -$4.06M -37,600 Closed
STA
636
Summit Trail Advisors
New York
– -$3.92M -36,360 Closed
Arrowstreet Capital
637
Arrowstreet Capital
Massachusetts
– -$3.78M -35,000 Closed
LOAMS
638
Lombard Odier Asset Management (Switzerland)
Switzerland
– -$3.67M -34,000 Closed
GCM
639
Grisanti Capital Management
New York
– -$3.52M -32,667 Closed
IG
640
ING Group
Netherlands
– -$3.2M -29,627 Closed
Capital Fund Management (CFM)
641
Capital Fund Management (CFM)
France
– -$2.83M -26,248 Closed
Tudor Investment Corp
642
Tudor Investment Corp
Connecticut
– -$2.36M -21,857 Closed
ECM
643
Endurant Capital Management
California
– -$2.12M -19,673 Closed
B
644
BP
United Kingdom
– -$1.94M -18,000 Closed
ARTA
645
A.R.T. Advisors
New York
– -$1.69M -15,700 Closed
SM
646
Sciencast Management
New Jersey
– -$1.39M -15,120 Closed
DTL
647
Dynamic Technology Lab
Singapore
– -$1.53M -14,202 Closed
CC
648
Cipher Capital
New York
– -$1.52M -14,084 Closed
PP
649
Paloma Partners
Connecticut
– -$1.51M -14,000 Closed
HPC
650
HM Payson & Co
Maine
– -$1.47M -13,573 Closed
24 25
26
27 28

DGX Hedge Fund Activity: Q4 2018 in Review

624 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q4 2018, worth a combined $9.91B — down 22% from $12.7B a quarter earlier.

Sellers outnumbered buyers: 110 funds closed out of DGX and 70 opened new positions — a net loss of 40 holders — while 217 trimmed existing stakes and 225 added.

The largest buyer was Levin Capital Strategies, opening a new position worth an estimated $135M. The largest seller was Bessemer Group, cutting an estimated $121M.

  • 624 institutional investors held Quest Diagnostics (DGX) as of Q4 2018, down from 673 in Q3 2018.
  • Funds reported $9.91B of Quest Diagnostics stock for Q4 2018, down 22% quarter-over-quarter.
  • 70 funds opened new Quest Diagnostics positions in Q4 2018 and 110 closed out, a net change of -40 holders.
  • The largest Quest Diagnostics buyer in Q4 2018 was Levin Capital Strategies, an estimated $135M added.
  • The largest Quest Diagnostics seller in Q4 2018 was Bessemer Group, an estimated $121M sold.

Based on aggregated 13F filings for Q4 2018.